Healthcare Global Enterprises Ltd (HCG ) closes
at ₹ 70.20 with a Loss
of - 1.90 %
on 25-April-2020 with formation of
a RED Candle on Daily Price Chart.
Why On Focus: Healthcare
Global Enterprises Ltd (HCG ) has received permission
from Drug Controller General of India to study the effectiveness of Plasma
therapy to improve the conditions of seriously ill Covid-19 patients & it has started trails
on 10 patients & expected to complete the investigations in next our weeks.
Valuations :
Healthcare Global Enterprises Ltd (HCG ) has posted a loss of Rs. 25 Cr in FY2019 and it will widen to Rs.68.9Cr in FY20 and seen reductions
in Losses to Rs.55.5Cr in FY21 & Rs.24.9Cr in FY22.
Since it’s a loss making company, we express
our inability to Value the Healthcare Global Enterprises
Ltd (HCG ), since our proprietary model values only Profit making Companies.
Disclaimer : We are / may going to take exposure shortly.
Join Us
at Telegram # https://t.me/TheNiftyNext
The author tracks
economic, behavioural and corporate tends, hoping to gauge good avenues of return
based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1
| e-Mail : Mail@NiftyNext.Com | Tel
+91 8802230836 | Telegram #
TheNiftyNext |
No comments:
Post a Comment
Thanks for Your Valuable comments. It will make Us to Serve You in Better Way. For Any STOCKS Query ,Please Call NiftyNext +91 880 2230 836.